A Win For Viking Therapeutics, Inc.
Mon, Dec 19, 2022 at 07:02 PM
Viking Therapeutics, Inc. (VKTX:NASDAQ) soared at $6.99, representing a gain of 73.9%. On Mon, Dec 19, 2022, VKTX:NASDAQ touched a New 2-Week High of $6.99. The stock got featured on our News Catalysts scanner on Mon, Dec 19, 2022 at 09:25 AM in the 'MISCELLANEOUS' category. From Mon, Dec 05, 2022, the stock recorded 70.00% Up Days and 45.45% Green Days
About Viking Therapeutics, Inc. (VKTX:NASDAQ)
Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.
Top 10 Gainers:
- Starry Group Holdings Inc. Class A (STRY:NYSE), 581.82%
- Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ), 268.07%
- Axcella Health Inc. (AXLA:NASDAQ), 165.27%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 103.86%
- Qumu Corporation (QUMU:NASDAQ), 100%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 73.88%
- Camber Energy, Inc. (CEI:NYSEMKT), 72.9%
- Landos Biopharma Inc. (LABP:NASDAQ), 56.31%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 49.26%